The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials

被引：12
|
作者：
Peyrin-Biroulet, Laurent [1 ,2 ]
Gower-Rousseau, Corinne [3 ,4 ,5 ]
机构：
[1] Univ Lorraine, INSERM U954, Allee Morvan, F-54511 Vandoeuvre Les Nancy, France
[2] Univ Lorraine, Dept Hepatogastroenterol, Allee Morvan, F-54511 Vandoeuvre Les Nancy, France
[3] Univ Hosp, EPIMAD Registry, Publ Hlth Epidemiol & Econ Hlth, Reg House Clin Res, F-59000 Lille, France
[4] Univ Hosp, INSERM, UMR 995, Int Ctr Inflammat Res LIRIC, F-59000 Lille, France
[5] IBD & Environm Factors Epidemiol & Funct Anal Grp, F-59000 Lille, France
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷 / 12期
关键词：
QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; VALIDATION; DISEASE;
D O I：
10.1093/ecco-jcc/jjw156
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1375 / 1377
页数：3
相关论文
共 50 条
  • [41] Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials
    Papapetropoulos, Spyridon
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (05) : 380 - 387
  • [42] Neuroimaging as a Selection Tool and Endpoint in Clinical and Pre-clinical Trials
    Muir, Keith W.
    Macrae, I. Mhairi
    TRANSLATIONAL STROKE RESEARCH, 2016, 7 (05) : 368 - 377
  • [43] Neuroimaging as a Selection Tool and Endpoint in Clinical and Pre-clinical Trials
    Keith W. Muir
    I. Mhairi Macrae
    Translational Stroke Research, 2016, 7 : 368 - 377
  • [44] How should we measure medication adherence in clinical trials and practice?
    Lee, Jeannie K.
    Grace, Karen A.
    Taylor, Allen J.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2006, 46 (04) : 420 - 423
  • [45] How should we measure medication adherence in clinical trials and practice?
    Lee, JK
    Grace, KA
    Foster, TG
    Truong, PQ
    Sun, HH
    Yang, HJ
    Erowele, GI
    Szkutnik, AJ
    Sullenberger, LE
    Taylor, AJ
    CIRCULATION, 2003, 108 (17) : 650 - 650
  • [46] Validation of the 'IBD Disk' in clinical practice
    Ferguson, A.
    Ding, N.
    Connell, W.
    Williams, J.
    Wright, E.
    Kamm, M.
    Thompson, A.
    Lust, M.
    Flanagan, E.
    Basnayake, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S472 - S472
  • [47] Is good clinical research practice for clinical trials good clinical practice?
    Yastrubetskaya, O
    Chiu, E
    OConnell, S
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1997, 12 (02) : 227 - 231
  • [48] Should You Become a Specialist in Clinical Hypertension?
    Kaplan, Norman M.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2007, 1 (01) : 94 - 94
  • [49] Improving the Reliability of Stroke Disability Grading in Clinical Trials and Clinical Practice The Rankin Focused Assessment (RFA)
    Saver, Jeffrey L.
    Filip, Bogdan
    Hamilton, Scott
    Yanes, Anna
    Craig, Sharon
    Cho, Michelle
    Conwit, Robin
    Starkman, Sidney
    STROKE, 2010, 41 (05) : 992 - 995
  • [50] Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
    Mota, Jose Mauricio
    Armstrong, Andrew J.
    Larson, Steven M.
    Fox, Josef J.
    Morris, Michael J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (04) : 522 - 530
12345